Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row : Nodal oligorecurrent prostate cancer.
Andrei FodorAndrea LanciaFrancesco CeciMaria PicchioMorten HoyerBarbara Alicja Jereczek-FossaPiet OstPaolo CastellucciElena IncertiNadia Di MuzioGianluca IngrossoPublished in: World journal of urology (2018)
Newer PET/CT radio-labeled tracers have increased disease detection in oligorecurrent prostate cancer patients. Growing evidence of their impact on metastasis-directed therapy encourages the use of the most advanced radiotherapy techniques in the clinical management of such patients.
Keyphrases
- prostate cancer
- pet ct
- lymph node
- radical prostatectomy
- end stage renal disease
- ejection fraction
- newly diagnosed
- early stage
- radiation therapy
- stem cells
- computed tomography
- squamous cell carcinoma
- mesenchymal stem cells
- locally advanced
- label free
- sentinel lymph node
- bone marrow
- loop mediated isothermal amplification